JP2023551535A5 - - Google Patents
Info
- Publication number
- JP2023551535A5 JP2023551535A5 JP2023533230A JP2023533230A JP2023551535A5 JP 2023551535 A5 JP2023551535 A5 JP 2023551535A5 JP 2023533230 A JP2023533230 A JP 2023533230A JP 2023533230 A JP2023533230 A JP 2023533230A JP 2023551535 A5 JP2023551535 A5 JP 2023551535A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- acid sequence
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063119753P | 2020-12-01 | 2020-12-01 | |
| US63/119,753 | 2020-12-01 | ||
| PCT/US2021/061453 WO2022119955A1 (en) | 2020-12-01 | 2021-12-01 | Methods and materials for treating t cell cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023551535A JP2023551535A (ja) | 2023-12-08 |
| JP2023551535A5 true JP2023551535A5 (enExample) | 2024-11-29 |
Family
ID=79021888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533230A Pending JP2023551535A (ja) | 2020-12-01 | 2021-12-01 | Ｔ細胞がんを治療するための方法および材料 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240002541A1 (enExample) |
| EP (1) | EP4255482A1 (enExample) |
| JP (1) | JP2023551535A (enExample) |
| CN (1) | CN116867519A (enExample) |
| AU (1) | AU2021392655A1 (enExample) |
| CA (1) | CA3203773A1 (enExample) |
| WO (1) | WO2022119955A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120076829A (zh) | 2022-10-18 | 2025-05-30 | 明治制果药业株式会社 | T细胞肿瘤的治疗剂 |
| US20260193361A1 (en) * | 2022-11-11 | 2026-07-09 | Pasithea Therapeutics Corp. | Anti-alpha5 integrin antibodies and uses thereof |
| IL326971A (en) * | 2023-09-05 | 2026-05-01 | Michele Pitaro | Single-chain variable fragment and molecules derived therefrom that bind the trvb5-1 fragment of the β chain of the human T-cell receptor |
| WO2025247325A1 (en) * | 2024-05-30 | 2025-12-04 | Hanx Biopharmaceuticals, (Wuhan) Ltd. | Antibody-drug conjugates targeting trbv12 and uses thereof |
| WO2026011103A1 (en) * | 2024-07-03 | 2026-01-08 | Yale University | Tcr-vβeta specific therapeutic molecules and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0590058B1 (en) * | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| GB9325182D0 (en) * | 1993-12-08 | 1994-02-09 | T Cell Sciences Inc | Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions |
| GB0128510D0 (en) * | 2001-11-28 | 2002-01-23 | Novartis Ag | Organic compounds |
| KR20180020202A (ko) * | 2015-06-01 | 2018-02-27 | 메디진 이뮤노테라피스 게엠바하 | T 세포 수용체 특이적 항체 |
| EP3192810A1 (en) * | 2016-01-14 | 2017-07-19 | Deutsches Krebsforschungszentrum | Psma binding antibody and uses thereof |
| US11807662B2 (en) * | 2017-05-16 | 2023-11-07 | The Johns Hopkins University | MANAbodies and methods of using |
| WO2020010250A2 (en) * | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| RU2712251C1 (ru) * | 2018-12-25 | 2020-01-27 | Федеральное государственное автономное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Гуманизированные антитела против участка бета цепи 9-го семейства TRBV9 TKP человека, и способы их применения |
| WO2020172598A1 (en) * | 2019-02-21 | 2020-08-27 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to t cells and uses thereof to treat autoimmune disorders |
| SG11202109122SA (en) * | 2019-02-21 | 2021-09-29 | Marengo Therapeutics Inc | Anti-tcr antibody molecules and uses thereof |
-
2021
- 2021-12-01 CN CN202180092544.3A patent/CN116867519A/zh active Pending
- 2021-12-01 WO PCT/US2021/061453 patent/WO2022119955A1/en not_active Ceased
- 2021-12-01 AU AU2021392655A patent/AU2021392655A1/en active Pending
- 2021-12-01 JP JP2023533230A patent/JP2023551535A/ja active Pending
- 2021-12-01 EP EP21830874.0A patent/EP4255482A1/en active Pending
- 2021-12-01 US US18/039,403 patent/US20240002541A1/en active Pending
- 2021-12-01 CA CA3203773A patent/CA3203773A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2410396C2 (ru) | Антитела, связывающиеся с рецепторами kir2dl1,-2,-3 и не связывающиеся с рецептором kir2ds4, и их терапевтическое применение | |
| JP2021522844A5 (enExample) | ||
| FI3823990T3 (fi) | Cd19:ään sitoutuvia raskasketjun vasta-aineita | |
| JP2021530251A5 (enExample) | ||
| JP2023527609A5 (enExample) | ||
| JP2020531438A5 (ja) | Ｎｋｇ２ｄ、ｃｄ１６、およびｈｌａ−ｅに結合するタンパク質 | |
| JP2022537931A5 (enExample) | ||
| RU2014131317A (ru) | Связывающие mica агенты | |
| RU2008149918A (ru) | Антитела к nkg2a и их применения | |
| RU2008129080A (ru) | Средства и способы лечения опухолевых заболеваний | |
| RU2012112340A (ru) | Гуманизированные моноклональные антитела к сеа с созревшей аффинностью | |
| JP2020529410A5 (enExample) | ||
| FI4010082T3 (fi) | Multispesifisiä vaihtelevan tcr-deltaketjun 1 vastaisia vasta-aineita | |
| JP2023511363A5 (ja) | 抗ｐｄ－ｌ１抗体 | |
| JP2022515152A5 (enExample) | ||
| JP2023511362A5 (ja) | 抗ｐｄ－ｌ１抗体 | |
| US20210040213A1 (en) | Immunomonotherapy for urothelial carcinoma | |
| FR2841905A1 (fr) | Fragments fab mutants de l'anticorps anti-cd4 chimere 13b8.2 et leurs applications | |
| WO2022040417A2 (en) | Cd3/cd25 antibodies for neuro-immune diseases | |
| JP2022513062A5 (enExample) | ||
| RU2003114744A (ru) | Деградированное антитело, являющееся агонистом тро | |
| JP2024508749A5 (enExample) | ||
| JP2024512135A5 (enExample) | ||
| JP2024530325A5 (enExample) | ||
| JP2024516098A5 (enExample) |